Gurbakhash Kaur, MD, discusses how quadruplet regimens, CAR T-cell therapy, and bispecific antibodies are reshaping the role of autologous transplant in multiple myeloma.
Gurbakhash Kaur, MD
Advertisement
Gurbakhash Kaur, MD, is an assistant professor of internal medicine at Mount Sinai Health System.
Articles by Gurbakhash Kaur, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
IMS Day 1 Recap: Bispecific and CAR T Data Shape Myeloma Treatment
2
Rusfertide Receives NCCN Category 1 Designation in Polycythemia Vera
3
Life-Years Saved Captures Gains—and Gaps—in Blood Cancer Treatment
4
Global Experts Define Consensus Criteria for Cure in Multiple Myeloma
5